(Q61956877)

English

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance (English)

0 references

medical condition

multiple myeloma

0 references

sponsor

Memorial Sloan Kettering Cancer Center

0 references

country

United States of America

0 references

start time

October 2011

0 references

end time

October 2019

0 references

number of participants

11

0 references

research intervention

(RS)-lenalidomide

0 references

thalidomide

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Stamford Hospital

0 references

Montefiore Medical Center

0 references

Northwell Health Orthopaedic Institute

0 references

Memorial Sloan Kettering Cancer Center

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01463670

0 references

(Q61956877)

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)